{rfName}
Sp

Indexed in

License and Use

Icono OpenAccess

Citations

3

Altmetrics

Analysis of institutional authors

Ortiz, AlbertoAuthor

Share

April 28, 2025
Publications
>
Article

Spanish Registry of Renal Patients: 2022 Report and evolutive analysis

Publicated to: Nefrologia. 45 (4): 312-328 - 2025-04-01 45(4), DOI: 10.1016/j.nefroe.2025.03.002

Authors:

Quiroga, B; Mahíllo, B; Mazuecos, A; Ortiz, A; Farnés, JC; Marrero, DH; Alemán, ST; de Pablos, MCS; Arévalo, OLR; Vidas, MM; Slon-Roblero, MF; Larrañaga, MA; Eguren, IM; Muñoz, MDV; Camblor, MR; Alia, IM; Caamaño, MEB; Galán, MAB; Lorenzo, JD; López, HG; Monzon, FEA; Marques, GG; Rodríguez-Benot, A; Domínguez-Gil, B; Alvarez, ES
[+]

Affiliations

Consejeria Salud, Registro Enfermos Renales Cron Tratamiento Sustitu, Direcc Gen Salud Publ & Atenc Salud Mental, Secc Informac Sanitaria,Principado Asturias, Oviedo, Spain - Author
Coordinac Auton Trasplantes Castilla & Leon, Leon, Spain - Author
Coordinadora Auton Trasplantes Galicia, Madrid, Spain - Author
DG Asistencia Sanitaria & Planificac, Dept San Aragon, Serv Evaluac & Acreditac, Madrid, Spain - Author
Direcc Gen Salud Publ, Serv Epidemiol, Castilla La Mancha, Spain - Author
Direcc Gen Salud Publ, Serv Estudios Epidemiol & Est Sanitarias, Valencia, Spain - Author
European Renal Assoc ERA, Wurzburg, Germany - Author
Hosp Puerta de Hierro, Serv Nefrol, Madrid, Spain - Author
Hosp San Pedro Alcantara, Serv Nefrol, Caceres, Spain - Author
Hosp San Pedro, Serv Nefrol, Logrono, Spain - Author
Hosp Univ Basurto, Serv Nefrol, Bilbao, Spain - Author
Hosp Univ Canarias, Serv Nefrol, Tenerife, Spain - Author
Hosp Univ Cent Asturias, Serv Nefrol, Oviedo, Spain - Author
Hosp Univ La Princesa, Serv Nefrol, Madrid, Spain - Author
Hosp Univ Navarra, Serv Nefrol, Pamplona, Spain - Author
Hosp Univ Puerta del Mar, Serv Nefrol, Cadiz, Spain - Author
Hosp Univ Reina Sofia, Serv Nefrol, Cordoba, Spain - Author
Hosp Univ Son Espases, Serv Nefrol, Palma De Mallorca, Spain - Author
IMIB, Direcc Gen Salud Publ, Serv Epidemiol, Murcia, Spain - Author
Minist Sanidad, Inst Nacl Gest Sanitaria INGESA, Subdirecc Gest Sanitaria, Madrid, Spain - Author
Org Catalana Trasplantaments, Dept Salut, Barcelona, Spain - Author
Org Nacl Trasplantes ONT, Madrid, Spain - Author
RICORS 2040, Barcelona, Spain - Author
SEN SENTRA, Grp Trasplante Renal, Madrid, Spain - Author
Serv Canario Salud, Direcc Gen Programas Asistenciales, Registro Enfermos Renales Canarias, Las Palmas Gran Canaria, Spain - Author
Soc Espanola Nefrol SEN, Madrid, Spain - Author
Soc Espanola Trasplantes SET, Barcelona, Spain - Author
Univ Autonoma Madrid, Fac Med, Med Dept, Madrid, Spain - Author
Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Nephrol & Hypertens Dept, Madrid, Spain - Author
Univ Autonoma Madrid, Madrid, Spain - Author
Univ Cantabria, Hosp Univ Marques de Valdecilla, Serv Nefrol, IDIVAL, Santander, Spain - Author
Univ La Laguna, Inst Tecnol Biomed, San Cristobal De La Lagun, Santa Cruz De T, Spain - Author
See more

Abstract

Introduction: Chronic kidney disease (CKD) will be the second leading cause of death in Spain by 2100. The Spanish Renal Disease Registry (REER) records the incidence, prevalence and mortality of all patients requiring renal replacement therapy (RRT) in Spain. Methods: Data are provided by Spanish autonomous regions and cities and the Organizaci & oacute;n Nacional de Trasplantes. Incidence and prevalence rates of RRT have been calculated (considering the Spanish population according to annual data from the Instituto Nacional de Estad & iacute;stica), as well as mortality of patients on RRT in our country during the period 2013-2022. Results: The incidence rate of RRT increased by 21% from 2013 to 2019, and stabilized thereafter, with a value of 152.2 cases per million population (pmp) in 2022, of which 77.8% were on haemodialysis (HD), 16.7% on peritoneal dialysis (PD) and 5.5% received a preemptive kidney transplant. Diabetes was the leading cause of CKD requiring RRT (21.8%), followed by other causes (21.6%). The incidence rate of RRT was 2-fold higher in men than in women, with large regional differences (1.93-fold for men and 2.55-fold for women in regions with the highest and lowest incidence rates). The prevalence rate of RRT was 1,391.1 pmp in 2022, showing a progressive increase over the last decade, mainly at the expense of an increase in the transplant population (765.0 pmp, 55.0%). In 2022, 3,404 kidney transplants were performed in Spain (71.7 pmp), which situates it as a world leader. The most frequent donor type was the donor after the neurological determination of death (51.5%), followed by the donor after the circulatory determination of death (37%). The overall annual mortality of RRT patients was 8.4% (13.8% for HD, 10.1% for PD and 3.9% for transplantation). Conclusions: Although it has stabilized somewhat in recent years, the incidence and prevalence of RRT continues to rise in Spain. Additional measures must be adopted to hamonize and optimize kidney health care. (c) 2024 Sociedad Espanola de Nefrolog & imath;a. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/ by-nc-nd/4.0/).
[+]

Keywords

Chronic kidney diseaseChronic kidney-diseaseDiagnosiEnfermedad renal cronicaEpidemiologiaEpidemiologyIncidenceIncidenciaKidney replacement therapKidney replacement therapyMortalidadMortalityPrevalencePrevalenciaRegistroRegistryTerapia renal sustitutiva

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Nefrologia due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2025, it was in position 42/133, thus managing to position itself as a Q2 (Segundo Cuartil), in the category Urology & Nephrology. Notably, the journal is positioned en el Cuartil Q3 para la agencia Scopus (SJR) en la categoría Nephrology.

Independientemente del impacto esperado determinado por el canal de difusión, es importante destacar el impacto real observado de la propia aportación.

Según las diferentes agencias de indexación, el número de citas acumuladas por esta publicación hasta la fecha 2026-04-06:

  • WoS: 1
[+]

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2026-04-06:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 9.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 10 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 2.
  • The number of mentions on the social network Facebook: 1 (Altmetric).
  • The number of mentions on the social network X (formerly Twitter): 2 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.
  • Additionally, the work has been submitted to a journal classified as Diamond in relation to this type of editorial policy.
[+]

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Germany; United Kingdom.

[+]